The granting of a patent to DMK Pharmaceuticals Corporation for an opioid to treat drug addiction could potentially open new revenue streams for the company. This is because the patent could lead to the development of a new product, which could in turn generate sales. However, the actual impact on the company's stock price will depend on various factors, including the market's perception of the potential profitability of the new product.